Michael Tran Email

Director, Analytical Development . Molecular Templates

Current Roles

Employees:
137
Revenue:
$24.2M
About
Molecular Templates (MTEM) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) platform. MTEM's first immunotoxin, MT-3724, is in clinical development for non-Hodgkin's lymphoma. Pipeline products for additional oncology targets are being advanced toward clinical development. For more information, please visit MTEM's website at www.mtem.com.
Molecular Templates Address
9301 Amberglen Blvd
Austin, TX
United States
Molecular Templates Email